Crescent Biopharma, Inc.
CBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001253689
In the last 90 days, Crescent Biopharma, Inc. insiders filed 1 open-market purchase and 7 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $532.6M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Crescent Biopharma, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +13 vs. Q3 2022
- Shares held
- 27.5M
- +1.56M (+6.0%) vs. Q3 2022
- Total value
- $83.3M
- +$69.0M (+482.2%) vs. Q3 2022
- New holders
- 18
- 8 more added
- Sold out
- 5
- 13 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $532.6M |
| Q1 2026 | 63 | $476.6M |
| Q4 2025 | 58 | $285.9M |
| Q3 2025 | 41 | $134.6M |
| Q2 2025 | 30 | $173.5M |
| Q1 2025 | 35 | $6.46M |
| Q4 2024 | 41 | $7.56M |
| Q3 2024 | 36 | $3.00M |
| Q2 2024 | 35 | $7.20M |
| Q1 2024 | 69 | $110.5M |
| Q4 2023 | 58 | $82.8M |
| Q3 2023 | 49 | $52.1M |
| Q2 2023 | 55 | $61.9M |
| Q1 2023 | 54 | $46.6M |
| Q4 2022 | 48 | $83.3M |
| Q3 2022 | 35 | $14.3M |
| Q2 2022 | 37 | $15.8M |
| Q1 2022 | 44 | $31.2M |
| Q4 2021 | 47 | $42.7M |
| Q3 2021 | 48 | $64.9M |
| Q2 2021 | 58 | $72.5M |
| Q1 2021 | 78 | $110.4M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Crescent Biopharma, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 76 | $230 | 0.00% | +76 | New |
| Bank of America Corp | 118 | $358 | 0.00% | −9,186−98.7% | Reduced |
| Wells Fargo & Company | 289 | $876 | 0.00% | +7+2.5% | Added |
| Carolinas Wealth Consulting LLC | 395 | $1.20K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 481 | $1.46K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 600 | $2.00K | 0.00% | 00.0% | Unchanged |
| Archer Investment Corp | 1,000 | $3.03K | 0.00% | +1,000 | New |
| Royal Bank of Canada | 2,000 | $6.00K | 0.00% | +1,800+900.0% | Added |
| Hartford Financial Management Inc. | 3,500 | $10.6K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 4,038 | $12.2K | 0.00% | −1,025−20.2% | Reduced |
| Freedom Wealth Alliance, LLC | 9,452 | $28.6K | 0.04% | +9,452 | New |
| Commonwealth Equity Services, LLC | 10,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 12,834 | $38.9K | 0.00% | +12,834 | New |
| Prentiss Smith & Co Inc | 15,120 | $45.8K | 0.04% | +1,120+8.0% | Added |
| Morgan Stanley | 16,342 | $49.5K | 0.00% | −27,288−62.5% | Reduced |
| Charles Schwab Investment Management Inc | 22,361 | $67.8K | 0.00% | +22,361 | New |
| Jane Street Group, LLC | 24,800 | $75.1K | 0.00% | +24,800 | New |
| Bank of New York Mellon Corp | 26,168 | $79.3K | 0.00% | −70−0.3% | Reduced |
| AE Wealth Management LLC | 26,898 | $81.5K | 0.00% | +26,898 | New |
| Pura Vida Investments, LLC | 31,615 | $95.8K | 0.02% | +31,615 | New |
| Ieq Capital, LLC | 38,363 | $116.2K | 0.00% | 00.0% | Unchanged |
| Beirne Wealth Consulting Services, LLC | 40,000 | $121.2K | 0.06% | +40,000 | New |
| Cubist Systematic Strategies, LLC | 48,297 | $146.3K | 0.00% | +48,297 | New |
| Citadel Advisors LLC | 50,322 | $152.5K | 0.00% | +50,322 | New |
| XTX Topco Ltd | 63,599 | $192.7K | 0.04% | +63,599 | New |
| Connor, Clark & Lunn Investment Management Ltd. | 65,288 | $197.8K | 0.00% | +65,288 | New |
| Simplex Trading, LLC | 67,567 | $204.0K | 0.01% | +65,386+2,998.0% | Added |
| Goldman Sachs Group Inc | 67,671 | $205.0K | 0.00% | +67,671 | New |
| Dimensional Fund Advisors LP | 74,278 | $225.0K | 0.00% | +74,278 | New |
| Bridgeway Capital Management, LLC | 80,400 | $243.6K | 0.01% | −75,000−48.3% | Reduced |
| Intellectus Partners, LLC | 81,730 | $247.6K | 0.09% | −38,770−32.2% | Reduced |
| Northern Trust Corp | 97,652 | $295.9K | 0.00% | −145−0.1% | Reduced |
| Eversept Partners, LP | 100,579 | $304.8K | 0.03% | 00.0% | Unchanged |
| Franklin Resources Inc | 120,671 | $365.6K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 133,612 | $404.8K | 0.00% | +133,612 | New |
| State Street Corp | 156,565 | $474.4K | 0.00% | +7,600+5.1% | Added |
| Two Sigma Advisers, LP | 191,800 | $581.2K | 0.00% | −15,100−7.3% | Reduced |
| Marshall Wace, LLP | 208,941 | $633.1K | 0.00% | +208,941 | New |
| Two Sigma Investments, LP | 218,363 | $661.6K | 0.00% | −9,940−4.4% | Reduced |
| Renaissance Technologies LLC | 257,000 | $779.0K | 0.00% | −269,300−51.2% | Reduced |
| First Manhattan Co | 314,141 | $951.8K | 0.00% | +314,141 | New |
| Geode Capital Management, LLC | 405,335 | $1.23M | 0.00% | +46,940+13.1% | Added |
| BlackRock Inc. | 758,696 | $2.30M | 0.00% | −7,189−0.9% | Reduced |
| Millennium Management LLC | 922,853 | $2.80M | 0.00% | +556,601+152.0% | Added |
| Acadian Asset Management LLC | 1,943,058 | $5.89M | 0.03% | −47,029−2.4% | Reduced |
| Vanguard Group Inc | 2,275,713 | $6.90M | 0.00% | +396,301+21.1% | Added |
| NEA Management Company, LLC | 8,967,706 | $27.2M | 1.53% | −121,335−1.3% | Reduced |
| BVF Inc | 9,544,262 | $28.9M | 1.22% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −36,630−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −21,577−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −17,262−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −17,600−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |